NASDAQ: CRVS · Biotechnology
Over the past week, Corvus Pharmaceuticals (CRVS) drew 8 mentions across Reddit, X and news, and the read is an Adanos Hold. That is too little tracked discussion to read a direction from, so the signal stays neutral. Wall Street is more constructive, with 8 of 8 analysts rating CRVS a buy.
Tracked discussion on CRVS is too thin this week to read a direction from, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from X at 0% to News at 14%. No other tracker puts the two side by side.
Across 8 analysts the consensus is a Strong Buy: 8 buy calls against 0 sell, with an average 12-month price target of $33.14.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week CRVS carries too few tracked mentions to weigh any of them, so the read is Hold rather than a clear buy or sell.
Analysts sit 93 points above the crowd average of 7%, the professionals are more constructive than retail. The split is inside the crowd: News reads 14% bullish while X sits at 0%, a 14-point spread that single-source trackers miss.
Over the 30-day window, Corvus Pharmaceuticals (CRVS) buzz held subdued around 18.3 while the price drifted up 0.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 840K shares. Updated Aug 13, 2026. Over the last 7 trading days, CRVS gained 8.1%. Buzz activity in the recent week averaged 21.6 and was relatively stable, swinging between 16.5 and 28.8. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 6 of the 10 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for CRVS and 1160+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CRVS sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 13, 2026.
Adanos will not call Corvus Pharmaceuticals (CRVS) either way right now. The last 7 days carry 8 tracked mentions across 2 sources, under the 10-mention floor, so the signal sits at a neutral hold with 40/100 conviction. This is a sentiment-based reading, not financial advice.
There is not enough tracked discussion on Corvus Pharmaceuticals (CRVS) to call it either way. The last 7 days carry 8 tracked mentions across 2 sources, under the 10-mention floor Adanos needs before it reads a direction. On the professional side, 8 of 8 analysts rate CRVS a buy.
Of the 8 analysts covering Corvus Pharmaceuticals (CRVS), 8 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $33.14. That puts the street ahead of the crowd, which averages 7% bullish.
Corvus Pharmaceuticals (CRVS) does not carry enough tracked discussion this week to have a readable sentiment. 8 mentions across 2 sources is under the 10-mention floor, so the signal stays neutral at 40/100 conviction.
Not for a reason found in the sentiment itself. Corvus Pharmaceuticals (CRVS) drew 8 tracked mentions in the last 7 days, too small a sample to read a direction from, so Adanos holds the signal neutral instead of calling a buy or sell off it.
News is the dominant discussion channel with 7 mentions (88% of total volume). X contributes 1 mention. There is too little of it to read a sentiment direction from, while news is the only source with rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CRVS's hold signal at 40/100 conviction reflects a sample too thin to read a direction from. It is a research shortcut, not financial advice.
The CRVS sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Corvus Pharmaceuticals with similar bullish ratios, signal direction and discussion volume. All 6 peers carry hold signals, pointing to broad mixed pressure rather than an CRVS-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key